CEAT Limited — Board Meeting, 18-03-2025: Outcome of Board Meeting

The Board of Directors has approved the appointment of Dr. Santrupt Misra as an Additional Non-Executive Independent Director for five years, pending shareholder approval via Postal Ballot. The Nomination and Remuneration Committee has been reconstituted to include Dr. Misra. The Board also greenlit the CEAT Employees Stock Option Scheme 2025 (ESOP 2025) for eligible employees, with the option pool set at 4,00,000 options. Additionally, policies related to Nomination and Remuneration and Material Subsidiaries were amended, with the initial capital for the Indonesia subsidiary set to IDR 10 billion (approximately INR 5.31 Cr).